You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Colorcon
Mallinckrodt
Medtronic
Harvard Business School
Moodys
Merck

Last Updated: August 9, 2020

DrugPatentWatch Database Preview

ERYC Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

US ANDA Litigation and Generic Entry Outlook for Eryc

A generic version of ERYC was approved as erythromycin by ARBOR PHARMS LLC on December 31st, 1969.

  Start Trial

US Patents and Regulatory Information for ERYC

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mayne Pharma ERYC erythromycin CAPSULE, DELAYED REL PELLETS;ORAL 050536-001 Approved Prior to Jan 1, 1982 AB RX Yes Yes   Start Trial   Start Trial   Start Trial
Johnson And Johnson ERYCETTE erythromycin SWAB;TOPICAL 050594-001 Feb 15, 1985 DISCN Yes No   Start Trial   Start Trial   Start Trial
Warner Chilcott Llc ERYC erythromycin CAPSULE, DELAYED REL PELLETS;ORAL 062338-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Parke Davis ERYC erythromycin CAPSULE, DELAYED REL PELLETS;ORAL 062546-001 Jul 25, 1985 DISCN No No   Start Trial   Start Trial   Start Trial
Parke Davis ERYC erythromycin CAPSULE, DELAYED REL PELLETS;ORAL 062618-001 Sep 25, 1985 DISCN No No   Start Trial   Start Trial   Start Trial
Hospira ERYC SPRINKLES erythromycin CAPSULE, DELAYED REL PELLETS;ORAL 050593-001 Jul 22, 1985 DISCN No No   Start Trial   Start Trial   Start Trial
Parke Davis ERYC 125 erythromycin CAPSULE, DELAYED REL PELLETS;ORAL 062648-001 Oct 24, 1985 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Merck
Baxter
AstraZeneca
Colorcon
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.